Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.

about

Modeling optimal cervical cancer prevention strategies in Nigeria.Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis Vaccines against human papillomavirus: perspectives for controlling cervical cancer.

P2860

Q33755002-A81EE64B-F3A0-4FE8-A04E-8F3BCD78ECE4 Q34011249-CCDB3781-8D80-49F2-959B-B9BD05D94535 Q36899058-BE67D92D-E5EC-4745-8413-3604711A8143

P2860

Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.

Item

http://www.wikidata.org/entity/Q36839786

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Cervical cancer screening foll ...... an papillomavirus vaccination.

@en

type

Item

label

Cervical cancer screening foll ...... an papillomavirus vaccination.

@en

prefLabel

Cervical cancer screening foll ...... an papillomavirus vaccination.

@en

P1476

Cervical cancer screening foll ...... an papillomavirus vaccination.

@en

P2093

Alex Ferenczy

http://www.w3.org/2001/XMLSchema#string

P2860

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

The global health burden of infection-associated cancers in the year 2002

Epidemiologic classification of human papillomavirus types associated with cervical cancer

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.

P304

319-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14796694.3.3.319

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo L. Franco

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6288167

http://www.w3.org/2001/XMLSchema#string

P698

17547527

http://www.w3.org/2001/XMLSchema#string

Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.

about

P2860

P2860

Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698